Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
100 participants
OBSERVATIONAL
2003-03-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System
NCT05358574
Total Shoulder Arthroplasty Multi-Center Registry
NCT03511586
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ComposiTCP
NCT07080450
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
NCT03726554
Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the Shoulder
NCT00408096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
S.E.S prosthesis
Consecutive series of patients with a S.E.S prosthesis.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A likelihood of obtaining relief of pain and improved function
* Full skeletal maturity
* Ability to follow instructions
* Good general health for age
* Willing to return for follow-up evaluations
Exclusion Criteria
* Neuro-muscular complications
* Inability to co-operate with and complete the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biomet France SARL
INDUSTRY
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurent BEGUIN, MD
Role: PRINCIPAL_INVESTIGATOR
Centre hospitalier Bellevue
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
De Dreef Van Zonnebos 13
Schilde, , Belgium
Clinique Générale
Annecy, , France
Clinique St Joseph
Chambéry, , France
Centre Hospitalier Général
Dax, , France
Clinique Chirurgicale Orthopédique A.D.R.
Maxéville, , France
Clinique St Jean
Montpellier, , France
IRCOS
Paris, , France
Clinique St Martin
Pessac, , France
Clinique Mutualiste
Saint-Etienne, , France
Polyclinique de l'Atlantique
Saint-Herblain, , France
Institut A. Tzanck
Saint-Laurent-du-Var, , France
Institut Calot
Saint-Laurent-du-Var, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMET FR 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.